Line 19: | Line 19: | ||
</body> | </body> | ||
+ | <h2>Bronze Medal</h2> | ||
+ | <h6>We have registered for iGEM, had a great summer and will attend the Giant Jamboree.<br/> | ||
+ | We have met the deliverables.<br/> | ||
+ | We have documented our project on our WIKI.<br/> | ||
+ | We will present a poster about our project at the Giant Jamboree.<br/> | ||
+ | We will present our project in a 20 minute presentation at the Giant Jamboree.<br/> | ||
+ | We filled in and submitted the Safety Forms and Judging Form.<br/> | ||
+ | We have documented a new BioBrick: CT33 with mCherry and Strep-tag II <a href="http://parts.igem.org/Part:BBa_K2356000">BBa_K2356000.</a><br/> | ||
+ | We have attributed all parts of our <a href="https://2017.igem.org/Team:TU-Eindhoven/Attributions">project.</a><br/> | ||
+ | We participated in the <a href="https://2017.igem.org/Team:TU-Eindhoven/InterLab">Interlab Measurement Study</a> and documented our results.<br/><br/></h6> | ||
+ | <h2>Silver Medal</h2> | ||
+ | <h6>We have experimentally validated our BioBrick.<br/> | ||
+ | We have done several <a href="https://2017.igem.org/Team:TU-Eindhoven/Collaborations">collaborations</a>, like the Card Game and a Postcard Exchange. The most meaningful collaboration was with <a href="https://2017.igem.org/Team:Potsdam/Collaborations">iGEM team Potsdam</a>, since we modeled their system.<br/> | ||
+ | We collaborated with the Dutch Institute for Health and environment to make our project <a href="https://2017.igem.org/Team:TU-Eindhoven/HP/Silver">Safe by Design</a> and we looked at the rules and regulations regarding GMO’s. We also spread knowledge and awareness about our project and synthetic biology in general via <a href="https://2017.igem.org/Team:TU-Eindhoven/Engagement">public events and conferences</a>.<br/><br/></h6> | ||
+ | <h2>Gold Medal</h2> | ||
+ | <h6>We have created an <a href="https://2017.igem.org/Team:TU-Eindhoven/HP/Gold_Integrated">application scenario</a> and thought about the risks and consequences of this scenario. We expanded and integrated Human Practices in our project by testing the viablility and risks of our application scenario by <a href="https://2017.igem.org/Team:TU-Eindhoven/Human_Practices/Stakeholders">talking to experts</a>.<br/> | ||
+ | We have improved existing BioBricks <a href="http://parts.igem.org/Part:BBa_K1761005">BBa_K1761005</a> and <a href="http://parts.igem.org/Part:BBa_K1761006">BBa_K1761006 </a>by sequencing them. We have also improved existing BioBrick <a href="http://parts.igem.org/Part:BBa_I0500">BBa_I0500</a> by optimizing the expression.<br/> | ||
+ | We have <a href="https://2017.igem.org/Team:TU-Eindhoven/Model">modeled </a>our system to gain more insight into the network formation of our system. We also showed the adaptiveness of our model by modeling the system of <a href="https://2017.igem.org/Team:Potsdam/Model">iGEM Potsdam</a>.<br/> | ||
+ | We have demonstrated that our project works.<br/></h6> | ||
</html> | </html> | ||
{{TU-Eindhoven_footer}} | {{TU-Eindhoven_footer}} |
Revision as of 12:28, 31 October 2017